Fifty years ago today, President John F. Kennedy signed a law that became a major milestone on the l...
In July, lurasidone—a dopamine receptor 2 (D2) blocker originally approved to treat schizophrenia—wa...
It has taken a century, but researchers are finally close to altering the outcomes of the most sever...
State laws requiring parity treatment for substance use disorder (SUD) that were enacted prior to th...
The Food and Drug Administration (FDA) yesterday approved Zohydro ER (hydrocodone bitartrate extende...
On Friday, the Food and Drug Administration (FDA) approved Vizamyl (flutemetamol) for use with posit...
In today's edition of his video series addressing key issues in mental health and its treatment, APA...
At the 60th annual meeting of the American Academy of Child and Adolescent Psychiatry this week in O...
President John F. Kennedy’s 1963 Community Mental Health Act was signed 50 years ago, but it resonat...
